Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement

Microparticles of a poorly water-soluble model drug, nevirapine (NEV) were prepared by supercritical antisolvent (SAS) method and simultaneously deposited on the surface of excipients such as lactose and microcrystalline cellulose in a single step to reduce drug–drug particle aggregation. In the pro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmaceutical sciences 2010-01, Vol.39 (1), p.164-174
Hauptverfasser: Sanganwar, Ganesh P., Sathigari, Sateeshkumar, Babu, R. Jayachandra, Gupta, Ram B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 174
container_issue 1
container_start_page 164
container_title European journal of pharmaceutical sciences
container_volume 39
creator Sanganwar, Ganesh P.
Sathigari, Sateeshkumar
Babu, R. Jayachandra
Gupta, Ram B.
description Microparticles of a poorly water-soluble model drug, nevirapine (NEV) were prepared by supercritical antisolvent (SAS) method and simultaneously deposited on the surface of excipients such as lactose and microcrystalline cellulose in a single step to reduce drug–drug particle aggregation. In the proposed method, termed supercritical antisolvent-drug excipient mixing (SAS-DEM), drug particles were precipitated in supercritical CO 2 vessel containing excipient particles in suspended state. Drug/excipient mixtures were characterized for surface morphology, crystallinity, drug–excipient physico-chemical interactions, and molecular state of drug. In addition, the drug content uniformity and dissolution rate were determined. A highly ordered NEV–excipient mixture was produced. The SAS-DEM treatment was effective in overcoming drug–drug particle aggregation and did not affect the crystallinity or physico-chemical properties of NEV. The produced drug/excipient mixture has a significantly faster dissolution rate as compared to SAS drug microparticles alone or when physically mixed with the excipients.
doi_str_mv 10.1016/j.ejps.2009.11.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733935895</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928098709003534</els_id><sourcerecordid>733935895</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-d8799e9d20b96b8f415fad5548474d7c32227d2022e88531d7751401dac8d3773</originalsourceid><addsrcrecordid>eNp9kU2P0zAQhiMEYsvCH-CAfEGcEvwR17bEBa34klbiAJwt157QqZI42E7Z_SH8X1xawY2TpfEzY8_zNs1zRjtG2fb1oYPDkjtOqekY6yhjD5oN08q0VHH6sNlQw3VLjVZXzZOcD5TSrVb0cXPFjNkyI9im-fUFp3Usboa4ZrKkGFZfMM7EzYH42E54h_N3EgcyoU9xcamgHyGfKjMcMbkFZyA_sewJ3HlcEOaSye6e5HWB5BNW3o11XMEcx2O9JROUfQxkiIkEzLW6_nkR5r2bPUwVedo8GtyY4dnlvG6-vX_39eZje_v5w6ebt7etF1qWNtRdDZjA6c5sd3romRxckLLXveqD8oJzruot56C1FCwoJVlPWXBeB6GUuG5enefWxX-skIudMHsYx7MPq4QwQmojK8nPZJWQc4LBLgknl-4to_aUhj3YUxr2lIZlzNY0atOLy_h1N0H413LRX4GXF8DlamlIVQDmvxznQkoteOXenDmoMo4IyWZfRXsImMAXGyL-7x-_AQ4TrH4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733935895</pqid></control><display><type>article</type><title>Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Sanganwar, Ganesh P. ; Sathigari, Sateeshkumar ; Babu, R. Jayachandra ; Gupta, Ram B.</creator><creatorcontrib>Sanganwar, Ganesh P. ; Sathigari, Sateeshkumar ; Babu, R. Jayachandra ; Gupta, Ram B.</creatorcontrib><description>Microparticles of a poorly water-soluble model drug, nevirapine (NEV) were prepared by supercritical antisolvent (SAS) method and simultaneously deposited on the surface of excipients such as lactose and microcrystalline cellulose in a single step to reduce drug–drug particle aggregation. In the proposed method, termed supercritical antisolvent-drug excipient mixing (SAS-DEM), drug particles were precipitated in supercritical CO 2 vessel containing excipient particles in suspended state. Drug/excipient mixtures were characterized for surface morphology, crystallinity, drug–excipient physico-chemical interactions, and molecular state of drug. In addition, the drug content uniformity and dissolution rate were determined. A highly ordered NEV–excipient mixture was produced. The SAS-DEM treatment was effective in overcoming drug–drug particle aggregation and did not affect the crystallinity or physico-chemical properties of NEV. The produced drug/excipient mixture has a significantly faster dissolution rate as compared to SAS drug microparticles alone or when physically mixed with the excipients.</description><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><identifier>DOI: 10.1016/j.ejps.2009.11.011</identifier><identifier>PMID: 19961931</identifier><language>eng</language><publisher>Kindlington: Elsevier B.V</publisher><subject>Biological and medical sciences ; Chemistry, Pharmaceutical - methods ; Chromatography, Supercritical Fluid - methods ; Crystallization - methods ; Dissolution rate enhancement ; Drug Carriers - chemical synthesis ; Drug Carriers - chemistry ; Drug Compounding - methods ; Excipients - chemistry ; General pharmacology ; High pressure stirred bed mixing ; Medical sciences ; Micro-mixing ; Microspheres ; Nevirapine - chemistry ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Solubility ; Supercritical antisolvent ; Surface Properties</subject><ispartof>European journal of pharmaceutical sciences, 2010-01, Vol.39 (1), p.164-174</ispartof><rights>2009 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2009 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-d8799e9d20b96b8f415fad5548474d7c32227d2022e88531d7751401dac8d3773</citedby><cites>FETCH-LOGICAL-c385t-d8799e9d20b96b8f415fad5548474d7c32227d2022e88531d7751401dac8d3773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejps.2009.11.011$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22355832$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19961931$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sanganwar, Ganesh P.</creatorcontrib><creatorcontrib>Sathigari, Sateeshkumar</creatorcontrib><creatorcontrib>Babu, R. Jayachandra</creatorcontrib><creatorcontrib>Gupta, Ram B.</creatorcontrib><title>Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement</title><title>European journal of pharmaceutical sciences</title><addtitle>Eur J Pharm Sci</addtitle><description>Microparticles of a poorly water-soluble model drug, nevirapine (NEV) were prepared by supercritical antisolvent (SAS) method and simultaneously deposited on the surface of excipients such as lactose and microcrystalline cellulose in a single step to reduce drug–drug particle aggregation. In the proposed method, termed supercritical antisolvent-drug excipient mixing (SAS-DEM), drug particles were precipitated in supercritical CO 2 vessel containing excipient particles in suspended state. Drug/excipient mixtures were characterized for surface morphology, crystallinity, drug–excipient physico-chemical interactions, and molecular state of drug. In addition, the drug content uniformity and dissolution rate were determined. A highly ordered NEV–excipient mixture was produced. The SAS-DEM treatment was effective in overcoming drug–drug particle aggregation and did not affect the crystallinity or physico-chemical properties of NEV. The produced drug/excipient mixture has a significantly faster dissolution rate as compared to SAS drug microparticles alone or when physically mixed with the excipients.</description><subject>Biological and medical sciences</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Chromatography, Supercritical Fluid - methods</subject><subject>Crystallization - methods</subject><subject>Dissolution rate enhancement</subject><subject>Drug Carriers - chemical synthesis</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Compounding - methods</subject><subject>Excipients - chemistry</subject><subject>General pharmacology</subject><subject>High pressure stirred bed mixing</subject><subject>Medical sciences</subject><subject>Micro-mixing</subject><subject>Microspheres</subject><subject>Nevirapine - chemistry</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Solubility</subject><subject>Supercritical antisolvent</subject><subject>Surface Properties</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2P0zAQhiMEYsvCH-CAfEGcEvwR17bEBa34klbiAJwt157QqZI42E7Z_SH8X1xawY2TpfEzY8_zNs1zRjtG2fb1oYPDkjtOqekY6yhjD5oN08q0VHH6sNlQw3VLjVZXzZOcD5TSrVb0cXPFjNkyI9im-fUFp3Usboa4ZrKkGFZfMM7EzYH42E54h_N3EgcyoU9xcamgHyGfKjMcMbkFZyA_sewJ3HlcEOaSye6e5HWB5BNW3o11XMEcx2O9JROUfQxkiIkEzLW6_nkR5r2bPUwVedo8GtyY4dnlvG6-vX_39eZje_v5w6ebt7etF1qWNtRdDZjA6c5sd3romRxckLLXveqD8oJzruot56C1FCwoJVlPWXBeB6GUuG5enefWxX-skIudMHsYx7MPq4QwQmojK8nPZJWQc4LBLgknl-4to_aUhj3YUxr2lIZlzNY0atOLy_h1N0H413LRX4GXF8DlamlIVQDmvxznQkoteOXenDmoMo4IyWZfRXsImMAXGyL-7x-_AQ4TrH4</recordid><startdate>20100131</startdate><enddate>20100131</enddate><creator>Sanganwar, Ganesh P.</creator><creator>Sathigari, Sateeshkumar</creator><creator>Babu, R. Jayachandra</creator><creator>Gupta, Ram B.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100131</creationdate><title>Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement</title><author>Sanganwar, Ganesh P. ; Sathigari, Sateeshkumar ; Babu, R. Jayachandra ; Gupta, Ram B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-d8799e9d20b96b8f415fad5548474d7c32227d2022e88531d7751401dac8d3773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological and medical sciences</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Chromatography, Supercritical Fluid - methods</topic><topic>Crystallization - methods</topic><topic>Dissolution rate enhancement</topic><topic>Drug Carriers - chemical synthesis</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Compounding - methods</topic><topic>Excipients - chemistry</topic><topic>General pharmacology</topic><topic>High pressure stirred bed mixing</topic><topic>Medical sciences</topic><topic>Micro-mixing</topic><topic>Microspheres</topic><topic>Nevirapine - chemistry</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Solubility</topic><topic>Supercritical antisolvent</topic><topic>Surface Properties</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sanganwar, Ganesh P.</creatorcontrib><creatorcontrib>Sathigari, Sateeshkumar</creatorcontrib><creatorcontrib>Babu, R. Jayachandra</creatorcontrib><creatorcontrib>Gupta, Ram B.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sanganwar, Ganesh P.</au><au>Sathigari, Sateeshkumar</au><au>Babu, R. Jayachandra</au><au>Gupta, Ram B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><addtitle>Eur J Pharm Sci</addtitle><date>2010-01-31</date><risdate>2010</risdate><volume>39</volume><issue>1</issue><spage>164</spage><epage>174</epage><pages>164-174</pages><issn>0928-0987</issn><eissn>1879-0720</eissn><abstract>Microparticles of a poorly water-soluble model drug, nevirapine (NEV) were prepared by supercritical antisolvent (SAS) method and simultaneously deposited on the surface of excipients such as lactose and microcrystalline cellulose in a single step to reduce drug–drug particle aggregation. In the proposed method, termed supercritical antisolvent-drug excipient mixing (SAS-DEM), drug particles were precipitated in supercritical CO 2 vessel containing excipient particles in suspended state. Drug/excipient mixtures were characterized for surface morphology, crystallinity, drug–excipient physico-chemical interactions, and molecular state of drug. In addition, the drug content uniformity and dissolution rate were determined. A highly ordered NEV–excipient mixture was produced. The SAS-DEM treatment was effective in overcoming drug–drug particle aggregation and did not affect the crystallinity or physico-chemical properties of NEV. The produced drug/excipient mixture has a significantly faster dissolution rate as compared to SAS drug microparticles alone or when physically mixed with the excipients.</abstract><cop>Kindlington</cop><pub>Elsevier B.V</pub><pmid>19961931</pmid><doi>10.1016/j.ejps.2009.11.011</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0928-0987
ispartof European journal of pharmaceutical sciences, 2010-01, Vol.39 (1), p.164-174
issn 0928-0987
1879-0720
language eng
recordid cdi_proquest_miscellaneous_733935895
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Biological and medical sciences
Chemistry, Pharmaceutical - methods
Chromatography, Supercritical Fluid - methods
Crystallization - methods
Dissolution rate enhancement
Drug Carriers - chemical synthesis
Drug Carriers - chemistry
Drug Compounding - methods
Excipients - chemistry
General pharmacology
High pressure stirred bed mixing
Medical sciences
Micro-mixing
Microspheres
Nevirapine - chemistry
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Solubility
Supercritical antisolvent
Surface Properties
title Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A10%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Simultaneous%20production%20and%20co-mixing%20of%20microparticles%20of%20nevirapine%20with%20excipients%20by%20supercritical%20antisolvent%20method%20for%20dissolution%20enhancement&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=Sanganwar,%20Ganesh%20P.&rft.date=2010-01-31&rft.volume=39&rft.issue=1&rft.spage=164&rft.epage=174&rft.pages=164-174&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/10.1016/j.ejps.2009.11.011&rft_dat=%3Cproquest_cross%3E733935895%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733935895&rft_id=info:pmid/19961931&rft_els_id=S0928098709003534&rfr_iscdi=true